secondary malignancies	is a	cancer
secondary malignancies	occur after	cancer treatment
secondary malignancies	associated with	radiotherapy
secondary malignancies	associated with	alkylating chemotherapy
secondary malignancies	associated with	platinum-based chemotherapy
secondary malignancies	associated with	topoisomerase inhibitors
therapy-related leukemia	is a	secondary malignancy
therapy-related leukemia	is a	leukemia
therapy-related leukemia	arises after	alkylating chemotherapy
therapy-related leukemia	characterized by	cytogenetic abnormalities
myelodysplastic syndrome	is a	secondary malignancy
myelodysplastic syndrome	can progress to	acute myeloid leukemia
acute myeloid leukemia	is a	hematologic malignancy
radiation therapy	increases risk of	secondary malignancies
alkylating chemotherapy	increases risk of	therapy-related leukemia
latency period	varies with	therapy-related leukemia
radiation dose	correlates with	risk of secondary malignancies
cranial irradiation	increases risk of	brain tumors
head and neck irradiation	increases risk of	thyroid cancer
breast irradiation	increases risk of	breast cancer
pediatric irradiation	increases risk of	brain tumors
meningioma	is a	secondary malignancy
meningioma	occurs after	cranial irradiation
glioma	is a	secondary malignancy
glioma	occurs after	cranial irradiation
sarcoma	is a	secondary malignancy
sarcoma	can arise after	radiotherapy
thyroid cancer	is a	secondary malignancy
thyroid cancer	associated with	neck irradiation
breast cancer	is a	secondary malignancy
breast cancer	occurs after	chest radiotherapy
second primary cancer	is a	secondary malignancy
lung cancer	may occur as	secondary malignancy
bone cancer	is a	secondary malignancy
skin cancer	is a	secondary malignancy
induced cancer	is a	secondary malignancy
lifetime surveillance	detects	secondary malignancies
imaging surveillance	detects	second primary cancers
biopsy	confirms	secondary malignancies
fine-needle aspiration	confirms	secondary malignancies
treatment planning	considers	secondary malignancies
surgical resection	used for	secondary malignancies
radiation therapy planning	aims to minimize	secondary malignancies
chemotherapy	increases risk of	secondary malignancies
genetic susceptibility	increases	risk of secondary malignancies
family history	increases	risk of secondary malignancies
age at exposure	modulates	risk of secondary malignancies
female sex	increases risk of	breast cancer
younger age at exposure	increases risk of	thyroid cancer
dose	increases risk of	secondary malignancies
dose-rate	influences	risk of secondary malignancies
dosimetry	informs	surveillance for secondary malignancies
central nervous system irradiation	associated with	brain tumors
cranial radiotherapy	linked to	meningioma
chest irradiation	linked to	breast cancer
neck irradiation	linked to	thyroid cancer
pelvic irradiation	linked to	ovarian cancer
alkylating agents	known to cause	leukemia
topoisomerase inhibitors	known to cause	secondary malignancies
cyclophosphamide	causes	leukemia
busulfan	causes	leukemia
chlorambucil	causes	leukemia
radiation-induced cancer	demonstrates	latency
solid tumor	is a	type of secondary malignancy
leukemia	is a	hematologic malignancy
therapy-related myeloid neoplasia	is a	secondary malignancy
myeloid neoplasia	includes	myelodysplastic syndrome
myelodysplastic syndrome	can progress to	acute leukemia
second primary thyroid cancer	is a	secondary malignancy
second primary breast cancer	is a	secondary malignancy
second primary sarcoma	is a	secondary malignancy
second primary brain tumor	is a	secondary malignancy
secondary malignancies	complicate	cancer survivorship
cancer survivorship	complicates	secondary malignancies
survivorship care	includes	surveillance for secondary malignancies
surveillance guidelines	address	secondary malignancies
clinical trial	evaluates	strategies to prevent secondary malignancies
prevention strategy	reduces	risk of secondary malignancies
radioprotective agent	reduces	risk of secondary malignancies
childhood cancer	increases risk of	secondary malignancies
adult cancer	increases risk of	secondary malignancies
treatment complication	includes	secondary malignancies
survival	affected by	secondary malignancies
mortality	increased by	secondary malignancies
readmission	associated with	secondary malignancies
palliative care	involved in	patients with secondary malignancies
end-of-life care	planned for	patients with secondary malignancies
oncology	manages	secondary malignancies
hematology	manages	secondary malignancies
therapy-related sarcoma	is a	secondary malignancy
myeloproliferative neoplasm	is a	secondary malignancy
bone marrow	site for	leukemia
second primary cancers	require	surveillance
radiation field	overlaps	multiple organs
latency	differs by	cancer type
genetic mutation	predisposes to	secondary malignancies
smoking	increases risk of	lung cancer
occupational exposure	increases risk of	secondary malignancies
follow-up imaging	monitors	secondary malignancies
imaging modality	monitors	second primary cancers
